0405 Clinical Trial 2019-0421 Clinical Trial 2019...
View lymphoma clinical trials and multiple myeloma clinical trials being conducted by MD Anderson Cancer Center, a top ranked cancer center.
This phase II trial studies how well acalabrutinib works in treating patients with mantle cell lymphoma that cannot tolerate ibrutinib. Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.